MCMichael Jason de la Cruz

Michael Jason de la Cruz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Michael Jason de la Cruz has a total of 202 co-authors. Here are the top co-authors by number of shared publications:

  • Tamir Gonen

    Department of Biological Chemistry, University of California, Los Angeles, Los Angeles, CA 90095

    8 shared publications
  • Johan Hattne

    Howard Hughes Medical Institute, University of California, Los Angeles, USA

    7 shared publications
  • Dan Shi

    UCLA-DOE Institute for Genomics and Proteomics Department of Biological Chemistry University of California 90095-1570 Los Angeles California USA

    6 shared publications
  • Kunio Nagashima

    Advanced Technology Program, SAIC-Frederick, Inc., NCI-Frederick, Frederick, Maryland 21702

    5 shared publications
  • Dinshaw J. Patel

    Structural Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA

    4 shared publications
  • Francis E. Reyes

    UCLA-DOE Institute for Genomics and Proteomics Department of Biological Chemistry University of California 90095-1570 Los Angeles California USA

    4 shared publications

Latest Publications

  • Open Access

    Structural basis for Lamassu-based antiviral immunity and its evolution from DNA repair machinery

    by Matthieu Haudiquet, Arpita Chakravarti, Zhiying Zhang, Josephine L. Ramirez, Alba Herrero del Valle, Paul Dominic B. Olinares, Rachel Lavenir, Massilia Aït Ahmed, M. Jason de la Cruz, Brian T. Chait, et al.

    Bacterial immune systems exhibit remarkable diversity and modularity, as a consequence of the continuous selective pressures imposed by phage predation. Despite recent mechanistic advances, the evolutionary origins of many antiphage immune systems remain elusive, especially for those that encode homologs of the structural maintenance of chromosomes (SMC) superfamily, which are essential for chromosome maintenance and DNA repair across domains of life. Here, we elucidate the structural basis and evolutionary emergence of Lamassu, a bacterial immune system family featuring diverse effectors but a core conserved SMC-like sensor. Using cryo-EM, we determined structures of the Vibrio cholerae Lamassu complex in both apo- and dsDNA-bound states, revealing unexpected stoichiometry and topological architectures. We further demonstrate how Lamassu specifically senses dsDNA ends in vitro and phage replication origins in vivo, thereby triggering the formation of LmuA tetramers that activate its Cap4 nuclease domain. Our findings reveal that Lamassu evolved via exaptation of the bacterial Rad50-Mre11 DNA repair system to form a compact, modular sensor for viral replication, exemplifying how cellular machinery can be co-opted for novel immune functions.


  • Open Access

    Structural basis for Lamassu-based antiviral immunity and its evolution from DNA repair machinery

    by Matthieu Haudiquet, Arpita Chakravarti, Zhiying Zhang, Josephine L. Ramirez, Alba Herrero del Valle, Paul Dominic B. Olinares, Rachel Lavenir, Massilia Aït Ahmed, M. Jason de la Cruz, Brian T. Chait, et al.

    Bacterial immune systems exhibit remarkable diversity and modularity, as a consequence of the continuous selective pressures imposed by phage predation. Despite recent mechanistic advances, the evolutionary origins of many antiphage immune systems remain elusive, especially for those that encode homologs of the Structural Maintenance of Chromosomes (SMC) superfamily, which are essential for chromosome maintenance and DNA repair across domains of life. Here, we elucidate the structural basis and evolutionary emergence of Lamassu, a bacterial immune system family featuring diverse effectors but a core conserved SMC-like sensor. Using cryo-EM, we determined structures of the Vibrio cholerae Lamassu complex in both apo- and dsDNA-bound states, revealing unexpected stoichiometry and topological architectures. We further demonstrate how Lamassu specifically senses dsDNA in vitro and phage replication origins in vivo , thereby triggering the formation of LmuA tetramers that activate the Cap4 nuclease domain. Our findings reveal that Lamassu evolved via exaptation of the bacterial Rad50-Mre11 DNA repair system to form a compact, modular sensor for viral replication, exemplifying how cellular machinery can be co-opted for novel immune functions.


  • Open Access

    Applying 3D ED/MicroED workflows toward the next frontiers

    by Mahira Aragon, Sarah E. J. Bowman, Chun-Hsing Chen, M. Jason de la Cruz, Daniel A. Decato, Edward T. Eng, Kristen M. Flatt, Sahil Gulati, Yuchen Li, Charles J. Lomba, et al.

    We report on the latest advancements in Microcrystal Electron Diffraction (3D ED/MicroED), as discussed during a symposium at the National Center for CryoEM Access and Training housed at the New York Structural Biology Center. This snapshot describes cutting-edge developments in various facets of the field and identifies potential avenues for continued progress. Key sections discuss instrumentation access, research applications for small molecules and biomacromolecules, data collection hardware and software, data reduction software, and finally reporting and validation. 3D ED/MicroED is still early in its wide adoption by the structural science community with ample opportunities for expansion, growth, and innovation.


  • Open Access

    Structural insights into DNMT5-mediated ATP-dependent high-fidelity epigenome maintenance

    by Juncheng Wang, Sandra Catania, Chongyuan Wang, M. Jason de la Cruz, Beiduo Rao, Hiten D. Madhani, Dinshaw J. Patel


  • Open Access

    Allosteric interactions prime androgen receptor dimerization and activation

    by Elizabeth V. Wasmuth, Arnaud Vanden Broeck, Justin R. LaClair, Elizabeth A. Hoover, Kayla E. Lawrence, Navid Paknejad, Kyrie Pappas, Doreen Matthies, Biran Wang, Weiran Feng, et al.

    Summary: The androgen receptor (AR) is a steroid receptor and master transcription factor that governs gene expression programs required for luminal development of prostate epithelium, formation of muscle tissue and maintenance of the male phenotype. AR misregulation is a hallmark of multiple malignancies, including prostate cancer, where AR hyperactivation and expansion of its transcriptome occur in part through AR gene amplification and interaction with oncoprotein cofactors. Despite its biological importance, how AR’s individual domains and its protein cofactors cooperate to bind DNA have remained elusive. Using a combination of reconstitution biochemistry and single particle cryo-electron microscopy (EM), we have isolated three conformational states of AR bound to DNA. We observe that AR forms a non-obligate dimer, with the buried dimer interface utilized by related ancestral nuclear receptors repurposed to facilitate cooperative DNA binding. We identify surfaces bridging AR’s domains responsible for allosteric communication, that are compromised in partial androgen insensitivity syndrome (PAIS), and are reinforced by AR’s oncoprotein cofactor, ERG, and DNA binding site motifs. Finally, we present evidence that this plastic dimer interface for transcriptional activation may have been adopted by AR at the expense of DNA binding. Our work highlights how fine-tuning of AR’s cooperative interactions translate to consequences in development and disease.


  • Open Access

    Molecular mechanisms of assembly and TRIP13-mediated remodeling of the human Shieldin complex

    by Wei Xie, Shengliu Wang, Juncheng Wang, M. Jason de la Cruz, Guotai Xu, Maurizio Scaltriti, Dinshaw J. Patel

    Significance: We report on X-ray and cryo-EM structural studies on the assembly of the human Shieldin complex composed of SHLD2, SHLD3, and REV7, as well as its complex with bound TRIP13 toward understanding the principles underlying TRIP13-mediated disassembly of Shieldin. Our studies identify a conformational heterodimeric alignment of open (O) and closed (C) conformers of REV7 when bound to a fused SHLD2–SHLD3 construct. The AAA + ATPase TRIP13 captures the N terminus of C-REV7 (REV NT ) within its central hexameric channel, with the rotatory motion associated with sequential ATP hydrolysis within individual TRIP13 subunits. This facilitates the stepwise pulling of the REV7 NT through the central channel, resulting in initial disassembly of C-REV7 followed by dissociation of the Shieldin complex.


  • Automation of Continuous-Rotation Data Collection for MicroED

    by M. Jason de la Cruz

    Automated coordination of microscope and camera functions for MicroED data collection simplifies the procedure for robust dataset acquisition and enables unattended sequential collection of many crystal targets. This chapter discusses the prerequisites for an algorithm of data collection automation for continuous-rotation MicroED and presents a practical protocol for achieving this goal using the popular TEM control software program SerialEM.


  • Open Access

    MicroED data collection with SerialEM

    by M. Jason de la Cruz, Michael W. Martynowycz, Johan Hattne, Tamir Gonen


  • Nanoemulsion-Based Delivery of Fluorescent PARP Inhibitors in Mouse Models of Small Cell Lung Cancer

    by Junior Gonzales, Susanne Kossatz, Sheryl Roberts, Giacomo Pirovano, Christian Brand, Carlos Pérez-Medina, Patrick Donabedian, M. Jason de la Cruz, Willem J. M. Mulder, Thomas Reiner

    The preclinical potential of many diagnostic and therapeutic small molecules is limited by their rapid washout kinetics and consequently modest pharmacological performances. In several cases, these could be improved by loading the small molecules into nanoparticulates, improving blood half-life, in vivo uptake and overall pharmacodynamics. In this study, we report a nanoemulsion (NE) encapsulated form of PARPi-FL. As a proof of concept, we used PARPi-FL, which is a fluorescently labeled sensor for olaparib, a FDA-approved small molecule inhibitor of the nuclear enzyme poly(ADP-ribose)polymerase 1 (PARP1). Encapsulated PARPi-FL showed increased blood half-life, and delineated subcutaneous xenografts of small cell lung cancer (SCLC), a fast-progressing disease where efficient treatment options remain an unmet clinical need. Our study demonstrates an effective method for expanding the circulation time of a fluorescent PARP inhibitor, highlighting the pharmacokinetic benefits of nanoemulsions as nanocarriers and confirming the value of PARPi-FL as an imaging agent targeting PARP1 in small cell lung cancer.